Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
08/11/2010 | CN101801370A Composition comprising sesamin component and arachidonic acid component |
08/11/2010 | CN101801363A Cholesterol-control agent |
08/11/2010 | CN101798356A Method for separating and extracting natural tea polysaccharide |
08/11/2010 | CN101798347A Monoclonal antibody for resisting high mobility group protein B1 |
08/11/2010 | CN101798284A Azepine brazilin compound and synthesis method thereof |
08/11/2010 | CN101797385A Oral calcium pharmaceutical composition |
08/11/2010 | CN101797376A Preparation method of modified collagen film |
08/11/2010 | CN101797371A Drug combination for weight-reducing massage |
08/11/2010 | CN101797346A Qiqing traditional Chinese medicine tea for lowering blood pressure, lowering blood lipid and lowering blood sugar level and preparation method thereof |
08/11/2010 | CN101797341A Chinese herbal medicine pill capable of clearing blood fat and lowering blood pressure |
08/11/2010 | CN101797330A Lipid regulating and meridians activating capsule |
08/11/2010 | CN101797312A Method for preparing Alisma extract capable of inhibiting alpha-glucuroide activity |
08/11/2010 | CN101797310A Fat reduction traditional Chinese medicine composite capable of removing dampness and absorbing clot as well as activating blood circulation and dissipating blood stasis |
08/11/2010 | CN101797282A Novel compound propolis preparation and preparation method thereof |
08/11/2010 | CN101797281A Medicinal granules for toxin elimination and blood fat reduction |
08/11/2010 | CN101797276A Compound vitamin nanoemulsion |
08/11/2010 | CN101797272A Fungus compound agent with antifatigue function |
08/11/2010 | CN101797270A Silkworm pupal oil fat emulsion intravenous fluid and preparation method |
08/11/2010 | CN101797259A Compound vitamin nanoemulsion |
08/11/2010 | CN101797245A Nanoparticulate fibrate formulations |
08/11/2010 | CN101797234A Pramlintide acetate slow release microballoon preparation and preparation method thereof |
08/11/2010 | CN101797233A Nanoparticulate fibrate formulations |
08/11/2010 | CN101797227A High oxidation resistance long chain fat emulsion injection and preparation method thereof |
08/11/2010 | CN101797226A High oxidation resistance medium/long chain fat emulsion injection and preparation method thereof |
08/11/2010 | CN101797225A High oxidation resistance long chain fat emulsion injection and preparation method thereof |
08/11/2010 | CN101317869B Method for extracting flavone from capillary wormwood |
08/11/2010 | CN101301476B Hydrophobic cyclodextrin clathrate and preparation and use thereof |
08/11/2010 | CN101219208B Medicine use of interleukin-22 |
08/11/2010 | CN101181520B Chinese traditional medicine tonic wine for tonifying kidney and nourishing blood |
08/11/2010 | CN101161268B Pharmaceutical composition of red sage root and cattail pollen |
08/11/2010 | CN101073574B Medicine for treating diabetes mellitus |
08/11/2010 | CN101011145B Edible Collybia albuminosa(Berk.) Petch stuffing |
08/11/2010 | CN100999546B Polypeptide compound with aza-containing heterocyclic modification and its application |
08/10/2010 | US7772429 chemical intermediate 11-((4R,6R)-4,5,6-trihydroxy-3-(R)-hydroxy-2-(S)-hydroxyhexylcarbamoyl)undecanoic acid; for making antilipemic agents; anticholesterol agents |
08/10/2010 | US7772407 (1S)-1,5-anhydro-1-[3-(1-benzothien-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity |
08/10/2010 | US7772402 Optically detectable organophosphonates |
08/10/2010 | US7772272 Method for enhancing glucose uptake into warm-blooded animal adipocytes |
08/10/2010 | US7772260 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases |
08/10/2010 | US7772249 Imidazo[1,2-b]pyridazine compound |
08/10/2010 | US7772232 Quinazolinyl compounds as inhibitors of potassium channel function |
08/10/2010 | US7772226 such as 3-(2-Butynyl)-2-(piperazin-1-yl)-3,5-dihydroimidazo[4,5-d]pyridazin-4-one trifluoroacetate, used as dipeptidyl peptidase-IV (DPPIV) inhibitors for the treatment of obesity and diabetes |
08/10/2010 | US7771771 fatty acid esters of phytosterols and phytostanols; preparing an edible oil or fat blend with elevated sterol and/or stanol content comprising liquid vegetable oil and a sterol and/or stanol fatty acid ester composition |
08/10/2010 | US7771748 Reducing smoking; side effect reduction |
08/10/2010 | CA2488592C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
08/10/2010 | CA2477967C Purine derivatives as kinase inhibitors |
08/10/2010 | CA2471745C 25-hydroxy vitamin d3 compositions |
08/10/2010 | CA2440714C Pyrazolopyrimidines as therapeutic agents |
08/10/2010 | CA2366800C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
08/10/2010 | CA2362864C New gymnemic acid derivatives, their preparation, pharmaceutical composition containing them and their medical use |
08/10/2010 | CA2249542C Pyrazole derivatives, their preparation and their use in pharmaceuticals |
08/10/2010 | CA2215827C O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof |
08/05/2010 | WO2010088574A1 Azabenzimidazoles and related analogs as sirtuin modulators |
08/05/2010 | WO2010088518A2 Heterocyclic modulators of gpr119 for treatment of disease |
08/05/2010 | WO2010088415A2 Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity |
08/05/2010 | WO2010088392A1 Carboxamide compounds and methods for using the same |
08/05/2010 | WO2010088375A2 Method of synergistically enhancing the therapeutic efficacy and safety of medications through a combination therapy |
08/05/2010 | WO2010088071A1 Use of whole grain materials with high resistant starch for satiety, reduction of food intake and weight management |
08/05/2010 | WO2010087577A2 Use of thymus capitatus extract, satureja hortensis extract, or carvacrol for treating metabolic diseases |
08/05/2010 | WO2010087517A1 Prophylactic or therapeutic agent for diseases associated with abnormal bone metabolism |
08/05/2010 | WO2010087454A1 Quinoline derivative |
08/05/2010 | WO2010087399A1 Urotensin-ii receptor antagonists |
08/05/2010 | WO2010087373A1 Method for producing extract of astaxanthin-containing yeast belonging to genus phaffia |
08/05/2010 | WO2010087244A1 Cyclic amino alcohol compound |
08/05/2010 | WO2010087243A1 Adiponectin-containing eating behavior control agent for oral administration |
08/05/2010 | WO2010087150A1 Gastric acid secretion inhibitor, and potassium channel inhibitor |
08/05/2010 | WO2010086820A1 4-amino-5-oxo-7, 8-dihydropyrimido [5,4-f] [1,4] oxazepin-6 (5h) -yl) phenyl derivatives, pharmaceutical compositions and uses thereof |
08/05/2010 | WO2010086646A1 Scriptaid isosteres and their use in therapy |
08/05/2010 | WO2010086484A1 Use of derivates of 6-substituted 3-phenylcoumarins and preparation of new derivates |
08/05/2010 | WO2010086454A1 N-(phenyl or pyridyl)prenylamine derivatives for the treatment of obesity, diabetes, cardiovascular diseases and other adiponectin-related diseases |
08/05/2010 | WO2010086438A1 Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof |
08/05/2010 | WO2010086411A1 Dpp-iv inhibitors for treatment of diabetes in paediatric patients |
08/05/2010 | WO2010086322A1 Composition comprising chicoric acid and/or derivatives thereof |
08/05/2010 | WO2010086101A1 Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof |
08/05/2010 | WO2010068913A3 Compositions of proton pump inhibitors, kits and methods of their use to treat diabetes |
08/05/2010 | WO2010066931A4 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug |
08/05/2010 | WO2010066901A3 Tetrahydrotriazine compounds for treating diseases associated with ampk activity |
08/05/2010 | WO2010046474A3 Chemoattractants inhibitors and the use thereof |
08/05/2010 | WO2010045303A3 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof |
08/05/2010 | WO2010017570A3 Pharmaceutical form comprising tetrahydrobiopterin |
08/05/2010 | WO2009100872A8 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
08/05/2010 | WO2003060149A9 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
08/05/2010 | US20100199366 Gene therapy using transposon-based vectors |
08/05/2010 | US20100197917 Coumarin derivatives useful as tnf alpha inhibitors |
08/05/2010 | US20100197911 Nitrogen-Containing Aromatic Derivatives |
08/05/2010 | US20100197907 Phosphorus-containing compounds & uses thereof |
08/05/2010 | US20100197803 Method for obtaining a sequoyitol-containing extract from a plant of the genus of trifolium, leguminosae or ginkoaceae and uses thereof |
08/05/2010 | US20100197801 Volatile Distillate By-Product of Mint Oil That Promotes Absorption and/or Bioavailability of Compounds of Bio-Medical and Nutritional Interest |
08/05/2010 | US20100197789 Anti-obesity agent and use thereof |
08/05/2010 | US20100197787 Composition for Prevention of Hypoglycemic Condition |
08/05/2010 | US20100197779 Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury |
08/05/2010 | US20100197778 Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases |
08/05/2010 | US20100197764 Antisense modulation of acyl coa cholesterol acyltransferase-2 expression |
08/05/2010 | US20100197744 Organic Compounds |
08/05/2010 | US20100197736 Cetp activity inhibitors |
08/05/2010 | US20100197735 Novel phenylurea inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof |
08/05/2010 | US20100197732 Repaglinide Substantially Free of Dimer Impurity |
08/05/2010 | US20100197726 Inhibitor of the differentiation of t cells into th1 cells |
08/05/2010 | US20100197714 Spiro-pyrano-pyrazole derivatives |
08/05/2010 | US20100197710 Methods Of Activating IRS-1 And AKT |
08/05/2010 | US20100197708 Indole compounds |